Initiation ot the Phase 2/3 GAIN trial of COR388, a novel bacterial virulence factor inhibitor for the treatment of Alzheimer’s Disease based on Phase 1 a/b safety, PK, biomarker and efficacy data

21 May 2020
17:20 - 17:40

Initiation ot the Phase 2/3 GAIN trial of COR388, a novel bacterial virulence factor inhibitor for the treatment of Alzheimer’s Disease based on Phase 1 a/b safety, PK, biomarker and efficacy data